Phase I Centre

The HKU Phase I Centre is a specialized clinical research facility dedicated to conducting early-phase clinical trials, particularly Phase I and first-in-human studies. Established by The University of Hong Kong and Queen Mary Hospital, the centre provides a comprehensive infrastructure for the evaluation of new drug candidates, biologics, and vaccines. It offers services ranging from study design and regulatory submission to clinical conduct and data management. The facility is equipped with advanced monitoring systems and a dedicated medical team to ensure participant safety and high-quality data collection. As a leading clinical trial hub in Asia, it collaborates extensively with global pharmaceutical companies and biotechnology firms to accelerate drug development.